Old Web
English
Sign In
Acemap
>
authorDetail
>
Peter Bercz
Peter Bercz
Idiopathic pulmonary fibrosis
Physical therapy
Medicine
FEV1/FVC ratio
Placebo
2
Papers
16
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Effect of pamrevlumab on the UCSD-SOBQ (University of California San Diego–Shortness of Breath Questionnaire) in patients with Idiopathic Pulmonary Fibrosis (IPF)
2018
European Respiratory Journal
Eduard Gorina
Tro Sekayan
Jeffrey J. Swigris
Peter LaCamera
Rafael Perez
Mark Hamblin
Joao Deandrade
John E. Fitzgerald
Peter Bercz
Ming Zhong
Elias Kouchakji
Peony Yu
Thomas B. Neff
Show All
Source
Cite
Save
Citations (1)
PRAISE, a randomized, placebo-controlled, double-blind Phase 2 clinical trial of pamrevlumab (FG-3019) in IPF patients
2017
European Respiratory Journal
Eduard Gorina
Luca Richeldi
Ganesh Raghu
Evans R. Fernandez-Perez
Ulrich Costabel
Carlo Albera
David J. Lederer
Kevin R. Flaherty
Neil Ettinger
Peter Bercz
Bhanu Singh
Rafael Perez
Jonathan G. Goldin
Elias Kouchakji
Seth Porter
Show All
Source
Cite
Save
Citations (15)
1